Cochrane Abstracts
Low‐molecular‐weight heparins for managing vaso‐occlusive crises in people with sickle cell disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Low‐molecular‐weight Heparins for Managing Vaso‐occlusive Crises in People With Sickle Cell Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432326/all/Low‐molecular‐weight_heparins_for_managing_vaso‐occlusive_crises_in_people_with_sickle_cell_disease. Accessed 17 September 2024.
Low‐molecular‐weight heparins for managing vaso‐occlusive crises in people with sickle cell disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432326/all/Low‐molecular‐weight_heparins_for_managing_vaso‐occlusive_crises_in_people_with_sickle_cell_disease. Accessed September 17, 2024.
Low‐molecular‐weight heparins for managing vaso‐occlusive crises in people with sickle cell disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432326/all/Low‐molecular‐weight_heparins_for_managing_vaso‐occlusive_crises_in_people_with_sickle_cell_disease
Low‐molecular‐weight Heparins for Managing Vaso‐occlusive Crises in People With Sickle Cell Disease [Internet]. In: Cochrane Abstracts. [cited 2024 September 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432326/all/Low‐molecular‐weight_heparins_for_managing_vaso‐occlusive_crises_in_people_with_sickle_cell_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Low‐molecular‐weight heparins for managing vaso‐occlusive crises in people with sickle cell disease
ID - 432326
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432326/all/Low‐molecular‐weight_heparins_for_managing_vaso‐occlusive_crises_in_people_with_sickle_cell_disease
DB - Evidence Central
DP - Unbound Medicine
ER -
